Ceruloplasmin and oxidized LDL colocalize in atherosclerotic lesions of hamster

Central European Journal of Biology

Volumn 6, Issue 1, 2011, Pages 23-31

  Stancu, Camelia ^a   Constantinescu, Elena ^a   Sima, Anca ^a  

^a INSTITUTE OF CELLULAR BIOLOGY AND PATHOLOGY NICOLAE SIMIONESCU   (Romania)

Author keywords

Atheroma; Ceruloplasmin; Fatty streak; Hyperlipemic hamster; LDL; Oxidized LDL

Indexed keywords

ANIMALIA; CRICETINAE;

EID: 78650389663     PISSN: 1895104X     EISSN: 16443632     Source Type: Journal    
DOI: 10.2478/s11535-010-0076-3     Document Type: Article

References (26)

1. Hansson G. K., Robertson A. K., Soderberg-Naucler C., Inflammation and atherosclerosis, Annu. Rev. Pathol., 2006, 1, 297-329.
2. Schwartz S. M., Galis Z. S., Rosenfeld M. E., Falk E., Plaque rupture in humans and mice, Arterioscler. Thromb. Vasc. Biol., 2007, 27, 705-713.
3. Sima A., Bulla A., Simionescu N., Experimental obstructive coronary atherosclerosis in the hyperlipidemic hamster, J. Submicrosc. Cytol. Pathol., 1990, 22, 1-16.
4. Simionescu M., Popov D., Sima A., Endothelial transcytosis in health and disease, Cell Tissue Res., 2009, 335, 27-40.
5. Holvoet P., van Cleemput J., Collen D., Vanhaecke J., Oxidized low density lipoprotein is a prognostic marker of transplant-associated coronary artery disease, Arterioscler. Thromb. Vasc. Biol., 2000, 20, 698-702.
6. Mehrabi M. R., Sinzinger H., Ekmekcioglu C., Tamaddon F., Plesch K., Glogar H. D., et al., Accumulation of oxidized LDL in human semilunar valves correlates with coronary atherosclerosis, Cardiovasc. Res., 2000, 45, 874-882.
7. Tabas I., Williams K. J., Boren J., Subendothelial lipoprotein retention as the initiating process in atherosclerosis: update and therapeutic implications, Circulation, 2007, 116, 1832-1844.
8. Fox P. L., Mukhopadhyay C., Ehrenwald E., Structure, oxidant activity, and cardiovascular mechanisms of human ceruloplasmin, Life Sci., 1995, 56, 1749-1758.
9. Shukla N., Maher J., Masters J., Angelini G. D., Jeremy J. Y., Does oxidative stress change ceruloplasmin from a protective to a vasculopathic factor?, Atherosclerosis, 2006, 187, 238-250.
10. Fleming R. E., Whitman I. P., Gitlin J. D., Induction of ceruloplasmin gene expression in rat lung during inflammation and hyperoxia, Am. J. Physiol., 1991, 260, L68-L74.
11. Nistor A., Simionescu M., Uptake of low density lipoproteins by the hamster lung. Interactions with capillary endothelium, Am. Rev. Respir. Dis., 1986, 134, 1266-1272.
12. Innerarity T. L., Pitas R. E., Mahley R. W., Lipoprotein-receptor interactions, Methods Enzymol., 1986, 129, 542-565.
13. Ryan T. P., Grover T. A., Aust S. D., Rat ceruloplasmin: resistance to proteolysis and kinetic comparison with human ceruloplasmin, Arch. Biochem. Biophys., 1992, 293, 1-8.
14. Fogelman A. M., Shechter I., Seager J., Hokom M., Child J. S., Edwards P. A., Malondialdehyde alteration of low density lipoproteins leads to cholesteryl ester accumulation in human monocytemacrophages, Proc. Natl. Acad. Sci. USA, 1980, 77, 2214-2218.
15. Niculescu L., Stancu C., Sima A., Toporan D., Simionescu M., The total peroxyl radical trapping potential in serum - an assay to define the stage of atherosclerosis, J. Cell. Mol. Med., 2001, 5, 285-294.
16. Mora R., Lupu F., Simionescu N., Prelesional events in atherogenesis. Colocalization of apolipoprotein B, unesterified cholesterol and extracellular phospholipid liposomes in the aorta of hyperlipidemic rabbit, Atherosclerosis, 1987, 67, 143-154.
17. Mertens A., Holvoet P., Oxidized LDL and HDL: antagonists in atherothrombosis, FASEB J., 2001, 15, 2073-2084.
18. Leake D. S., Does an acidic pH explain why low density lipoprotein is oxidised in atherosclerotic lesions?, Atherosclerosis, 1997, 129, 149-157.
19. Awadallah S. M., Hamad M., Jbarah I., Salem N. M., Mubarak M. S., Autoantibodies against oxidized LDL correlate with serum concentrations of ceruloplasmin in patients with cardiovascular disease, Clin. Chim. Acta, 2006, 365, 330-336.
20. Ehrenwald E., Chisolm G. M., Fox P. L., Intact human ceruloplasmin oxidatively modifies low density lipoprotein, J. Clin. Invest., 1994, 93, 1493-1501.
21. Lamb D. J., Leake D. S., Acidic pH enables caeruloplasmin to catalyse the modification of low-density lipoprotein, FEBS Lett., 1994, 338, 122-126.
22. Tavassoli M., Kishimoto T., Kataoka M., Liver endothelium mediates the hepatocyte's uptake of ceruloplasmin, J. Cell. Biol., 1986, 102, 1298-1303.
23. Simionescu N., Sima A., Dobrian A., Tirziu D., Simionescu M., Pathobiochemical changes of the arterial wall at the inception of atherosclerosis, Curr. Top. Pathol., 1993, 87, 1-45.
24. Mehta D., Malik A. B., Signaling mechanisms regulating endothelial permeability, Physiol. Rev., 2006, 86, 279-367.
25. Swain J. A., Darley-Usmar V., Gutteridge J. M., Peroxynitrite releases copper from caeruloplasmin: implications for atherosclerosis, FEBS Lett., 1994, 342, 49-52.
26. Herpfer I., Greilberger J., Ledinski G., Widner B., Fuchs D., Jurgens G., Neopterin and 7, 8-dihydroneopterin interfere with low density lipoprotein oxidation mediated by peroxynitrite and/or copper, Free Radic. Res., 2002, 36, 509-520.